Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release

Journal of Surgical Research

Volumn 76, Issue 1, 1998, Pages 91-94

  Johnson, Jeffrey L ^a   Moore, Ernest E ^a   Tamura, Douglas Y ^a   Zallen, Garret ^a   Biffl, Walter L ^a   Silliman, Christopher C ^a  

^a DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

Degranulation; IL 6; Neutrophil; PAF; Proteinase

Indexed keywords

6 (2 CHLOROPHENYL) 8 DIPROPYLCARBAMOYL 8,9 DIHYDRO 1 METHYL 4H,7H CYCLOPENTA[4,5]THIENO[3,2 F][1,2,4]TRIAZOLO[4,3 A][1,4]DIAZEPINE; CD11B ANTIGEN; CD18 ANTIGEN; CELL ADHESION MOLECULE; ELASTASE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTEGRIN; INTERLEUKIN 6; REACTIVE OXYGEN METABOLITE; THROMBOCYTE ACTIVATING FACTOR;

ADULT RESPIRATORY DISTRESS SYNDROME; CELL ADHESION; CONFERENCE PAPER; CONTROLLED STUDY; CRITICAL ILLNESS; CYTOTOXICITY; DEGRANULATION; ENZYME RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; MULTIPLE ORGAN FAILURE; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0031926788     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5295     Document Type: Conference Paper

References (20)

1. Biffl W. L., Moore E. E., Moore F. A. Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation. Ann. Surg. 224:1996;647.
2. Cruickshank A. M., Fraser W. D., Burns H. J. G., van Damme J., Shenkin A. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin. Sci. 79:1990;161.
3. Roumen R. M. H., Hendriks T., van der Ven-Jongekrijg J., Nieuwenhuijzen G. A. P., Sauerwein R. W., van der Meer J. W. M., Goris J. A. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock and severe blunt trauma. Ann. Surg. 218:1993;769.
4. Heuer H. O. WEB 2347: Pharmacology of a new very potent and long acting hetrazepinoic PAF-antagonist and its action in repeatedly sensitized guinea-pigs. J. Lipid Mediat. 4:1991;39.
5. Biffl W. L., Moore E. E., Moore F. A., Barnett C. C., Silliman C. C., Peterson V. M. Interleukin-6 stimulates neutrophil production of platelet-activating factor. J. Leukocyte Biol. 59:1996;569.
6. Hoch R. C., Rodriguez R., Manning T., Bishop M., Mead P., Shoemaker W. C., Abraham E. Effects of accidental trauma on cytokine and endotoxin production. Crit. Care Med. 21:1993;839.
7. Meduri G. U., Headley S., Kohler G. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: Plasma IL-1β and IL-6 levels are consistent and efficient predictors of outcome over time. Chest. 107:1995;1062.
8. Partrick D. A., Moore F. A., Moore E. E., Biffl W. L., Sauaia A., Barnett C. C. The inflammatory profile of interleukin-6, interleukin-8 and soluble intercellular adhesion molecule-1 in postinjury multiple organ failure. Am. J. Surg. 172:1996;425.
9. Lue C., Kiyono H., McGhee J. R., Fjihashi K., Kishimoto T., Hirano T., Mestecky J. Recombinant human interleukin-6 (rhIL-6) promotes the terminal differentiation ofin vivo. Cell. Immunol. 132:1991;423.
10. Lorre K., van Damme J., Verwilghem J., Baroja M. L., Ceuppens J. L. IL-6 is an accessory signal in the alternative CD2-mediated pathway of T cell activation. J. Immunol. 144:1990;4681.
11. Tilg H., Dinarello C. A., Mier J. W. IL-6 and APPs: Anti-inflammatory and immunosuppressive mediators. Immunol. Today. 18:1997;428.
12. Mizuhara H., O'Neill E., Seki N., Ogawa T., Kusunoki C., Otsuka K., Satoh S., Niwa M., Senoh H., Fujiwara H. T cell activation-associated hepatic injury: Mediation by tumor necrosis factors and protection by interleukin 6. J. Exp. Med. 179:1994;1529.
13. Biffl W. L., Moore E. E., Moore F. A., Carl V. S., Kim F. J., Franciose R. J. Interleukin-6 potentiates neutrophil priming with platelet-activating factor. Arch. Surg. 129:1994;1131.
14. Mullen P. G., Windsor A. C. J., Walsh C. J., Fowler A. A., Sugerman H. J. Tumor necrosis factor-α and interleukin-6 selectively regulate neutrophil functionin vitro. J. Surg. Res. 58:1995;124.
15. Rosenbloom A. J., Pinsky M. R., Bryant J. L., Shin A., Tran T., Whiteside T. Leukocyte activation in the peripheral blood of patients with cirrhosis of the liver and SIRS. J. Am. Med. Assoc. 274:1995;58.
16. Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., Faggioni R., Luini W., van Hinsbergh V., Sozzani S., Bussolino F., Poli V., Ciliberto G., Mantovani A. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 6:1997;315.
17. Limb G. A., Hamblin A. S., Wolstencroft R. A., Dumonde D. C. Selective up-regulation of human granulocyte integrins and complement receptor 1 by cytokines. Immunology. 74:1991;696.
18. Oka Y., Murata A., Nishijima J., Yasuda T., HIraoka N., Ohmachi Y., Yasuda T., Kitagawa K., Toda H., Tanaka N. Enhanced attachment and elastase-releasing capacity of neutrophils after surgery. Am. J. Surg. 167:1994;405.
19. Kawamura T., Wakusawa R., Okada K., Inada S. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: Participation of interleukin 8 and 6 in reperfusion injury. Can. J. Anaesth. 40:1993;1016.
20. Bank U., Reinhold D., Kunz D., Schulz H.-U., Schneemilch C., Brandt W., Ansorge S. Effects of interleukin-6 (IL-6) and transforming growth factor-β (TGF-β) on neutrophil elastase release. Inflammation. 19:1995;83.